In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 34978850.
- Also identified by DOI 10.7326/J21-0004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Joseph P, Roshandel G, Gao P, et al. <b>Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.</b> Lancet. 2021;398:1133-46. 34469765.
Medical subject headings
- Cardiovascular Diseases